Accelerating patient access to oncology medicines with multiple indications in Europe

Background: In recent years, innovation in oncology has created new challenges for pricing and reimbursement systems. Oncology medicines with multiple indications face a number of access challenges: (1) the number of assessments and administrative burden; (2) aligning price to different values of th...

Descripción completa

Detalles Bibliográficos
Autores principales: Lawlor, R., Wilsdon, T., Darquennes, E., Hemelsoet, D., Huismans, J., Normand, R., Roediger, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Routledge 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381976/
https://www.ncbi.nlm.nih.gov/pubmed/34436506
http://dx.doi.org/10.1080/20016689.2021.1964791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8381976/
https://www.ncbi.nlm.nih.gov/pubmed/34436506
http://dx.doi.org/10.1080/20016689.2021.1964791

Ejemplares similares